Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Bruker Opens Two New Centers of Excellence in Mumbai and Bengaluru

Published: Thursday, February 28, 2013
Last Updated: Wednesday, March 13, 2013
Bookmark and Share
The applications, training and service centers will offer extended applications laboratories and customer support capabilities.

Bruker celebrates the grand openings of its new Mumbai and Bengaluru Centers of Excellence (CoE). For over three decades, Bruker has grown its presence in India, with sales and service capabilities in most major cities in India, including New Delhi, Mumbai, Bengaluru, Chennai, Kolkata, Lucknow and Hyderabad, as well as several other Indian cities. This year, Bruker is expecting approximately $50 million in revenue in India, employing over 100 staff, complemented by several high-quality distributors with service capabilities for some of Bruker’s product lines.

Bruker’s new Centers of Excellence in Mumbai and Bengaluru now offer a new, even higher level of customer support in the important and growing Indian markets for scientific and analytical instrumentation. Bringing together a wide range of Bruker divisional operations in India, the new CoE facilities offer our customers access to multi-technology applications, training and demonstration capabilities. These Centers of Excellence will also aim to support research collaborations between Bruker and key customers in India. Their locations were chosen for their proximity to major academic, government and industrial research laboratories, and also to major hubs for the strong Indian pharma, biotechnology and CRO industry, as well as to major clinical research centers, and to important centers for the cement, metals, manufacturing, food and other industries.

Dr. Frank Laukien, Bruker’s President and CEO, commented: “With this significant investment in our two new Centers of Excellence, Bruker has taken a major step forward in India to provide highest-level support for the outstanding and rapidly growing Indian research, industrial and clinical communities.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Friday, May 20, 2016
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
MRSA Uses Decoys to Evade a Last-Resort Antibiotic
Researchers at Imperial College London have discovered that MRSA releases decoy molecules that allow them to escape being killed by the antibiotic.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Nanomedicine for Breast Cancer Treatment
Using nanoparticles measuring only billionths of a meter in size, doctors are able to deliver drug molecules directly to the affected tissue.
Preventing "Friendly Fire" in the Pancreas
Researchers inhibit process that leads to the body attacking its own insulin-producing cells.
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
3D-Printed Heart-On-A-Chip with Integrated Sensors
Researchers have created the first 3D-printed organ-on-a-chip with integrated sensors, paving the way for more complex, customizable devices.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos